Using artificial intelligence to check uterine artery embolization results
Part of Cancer clinical trials.
This study is looking at whether a computer program (artificial intelligence) can help doctors better evaluate how well uterine artery embolization (UAE) worked for treating fibroids. The program analyzes the X-ray images taken during the procedure to see if it might improve outcomes for women with fibroids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older.
- You must have uterine fibroids that cause symptoms like heavy bleeding, pelvic pain, or a feeling of fullness.
- You must have already had a procedure called uterine artery embolization (UAE) to treat your fibroids.
- You need to have imaging records from your procedure available, or you must be able to give permission (consent) to participate.
- You must not have missing follow-up information, and your imaging must be clear and complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for painful or heavy menstrual bleeding caused by uterine fibroids: high-intensity focused ultrasound (HIFU) and myomectomy (surgery to remove fibroids). It may help you decide which option fits your needs.
This trial uses special contrast-enhanced ultrasound (CEUS and SHAPE) to take detailed images of uterine fibroids before and after a procedure called uterine artery embolization (UAE). It aims to help doctors better understand how fibroids respond to treatment.
This study uses artificial intelligence to make ultrasound scans more accurate for diagnosing conditions like endometriosis and other uterine problems. If you're planning fertility treatment or surgery, this could help doctors find issues earlier.
This study uses an artificial intelligence (AI) tool to analyze ultrasound images of the uterus to see if it can find early signs of endometrial cancer or a condition called atypical hyperplasia (which can lead to cancer). It may help women with postmenopausal bleeding avoid more invasive biopsies.
This trial tests a new particle material, Bearing nsPVA, for uterine artery embolization (UAE), a procedure that blocks blood flow to fibroids to shrink them and reduce symptoms like heavy bleeding or pain. It aims to see if this material is safe and effective for women with symptomatic fibroids.
This study aims to develop and test a tool that predicts whether uterine fibroids affect a woman's ability to get pregnant. By joining, you help doctors better understand how fibroids impact fertility and improve future care for women like you.
Hear when a new Uterine Fibroids (UF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.